Cargando…
Efficacy and tolerability of pramipexole for the treatment of primary restless leg syndrome: a meta-analysis of randomized placebo-controlled trials
Primary restless leg syndrome (RLS) is a common sensory-motor disorder that is characterized by an irresistible urge to move the limbs and unpleasant sensations in the legs, which affects 1.9%–4.6% adults. Pramipexole, a potent dopamine D(2/3) agonist, is recommended as “effective” in the short-term...
Autores principales: | Zhang, Wei, Wang, Ye, Cong, Shu Yan, Nao, Jian Fei, Feng, Juan, Bi, Guo Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3742349/ https://www.ncbi.nlm.nih.gov/pubmed/23950645 http://dx.doi.org/10.2147/NDT.S49454 |
Ejemplares similares
-
Restless legs syndrome: differential diagnosis and management with pramipexole
por: Brindani, Francesca, et al.
Publicado: (2009) -
Pramipexole: new use for an old drug – the potential use of pramipexole in the treatment of restless legs syndrome
por: Benbir, Gulcin, et al.
Publicado: (2006) -
Pramipexole in restless legs syndrome: an evidence-based review of its effectiveness on clinical outcomes
por: Winlow, William
Publicado: (2005) -
Does Pramipexole Treatment Improve Headache in Patients with Concomitant Migraine and Restless Legs Syndrome?
por: Suzuki, Keisuke, et al.
Publicado: (2013) -
Restless legs syndrome augmentation among Japanese patients receiving pramipexole therapy: Rate and risk factors in a retrospective study
por: Takahashi, Masayoshi, et al.
Publicado: (2017)